Clinical Trial Update: Photodynamic Therapy for the Prevention of Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating photodynamic therapy for prevention of lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Squamous Cell Carcinoma of the Lung

Snippet

Sponsor: University College, London | Conditions: Squamous Cell Lung Cancer, Lung Cancer | Phase 2, Phase 3 | Status: WITHDRAWN